BioCardia raises $775k in private placement of common stock and warrants

BioCardia, Inc.

Gross proceeds of ~$775k from sale of 406,818 shares and 406,818 warrants at $1.905/unit.
Warrants exercisable at $1.905/share, expire Apr 23, 2030 or upon Japan PMDA approval of CardiAMP.
Directors/executives invest $575k total: Andrew Blank $250k, Simon Stertzer $200k, Peter Altman $50k, others.
Net proceeds to be used for general corporate purposes; closing expected Apr 23, 2025.
Company agrees to file resale registration statement by May 3, 2025 for shares and warrant shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.